A cancer diagnosis is life changing. For most patients, treatment is complex, involving a variety of medications that may include chemotherapy, immunotherapy or hormone therapy, as well as supportive medications such as anti-emetics. The drugs used to treat cancer are aggressive and can cause serious adverse effects if the dosage is too high or be ineffective in treating the disease if the dosage is not high enough.
When CSAM ProSang launched more than 50 years ago to a small number of users in Sweden, it was hard to imagine the product would grow to become the leading blood, cell, and tissue management solution in Scandinavia.
The story of CSAM ProSang – an advanced Laboratory Information System (LIS) that simplifies the entire management of blood,
CSAM delivered an impactful and highly successful program at this year’s Vitalis conference – the largest eHealth conference in Sweden. The three-day event provided an ideal venue for CSAM to meet with existing and potential customers, make a strong connection between its leading products (Picsara, ProSang, Cytodose and Partus) and the CSAM brand, and launch the company’s newest product CSAM CIMA (clinical imaging mobile application).
CSAM CIMA brings the power of clinical imaging to a user’s mobile device
OSLO, Norway – CSAM, the leading provider of niche eHealth solutions in the Nordics, is pleased to announce the launch of CSAM CIMA, the company’s first-ever clinical imaging mobile application. The CSAM CIMA app simplifies and secures the process of capturing,
Paratus technology will strengthen CSAM’s position in the emergency and acute market
OSLO, Norway – CSAM is pleased to announce the appointment of Linus Fred to the position of Managing Director for CSAM Sweden. In his new role, Linus will be responsible for all of CSAM’s operations in the Swedish market.
– Linus has shown tremendous leadership in his short time at CSAM, said Sverre Flatby,
OSLO, Norway – CSAM is pleased to announce the appointment of Jennifer Goode to the position of Communications Director. In her new role, Jennifer will be responsible for all internal and external communications at CSAM.
– Building CSAM’s brand and reputation is a key focus for the company across all markets, and I am excited to have Jennifer on-board to drive our continued progress in this area,
CSAM – the company behind ProSang, Picsara, Partus and Cytodose – and the leading provider of niche eHealth solutions in the Nordics will be displaying its innovative specialized solutions at Vitalis 2018.
Vitalis is the largest eHealth conference in Sweden and takes place from April 24 to 26 at the Swedish Exhibition and Conference Centre in Gothenburg.
Over the past 20 years, CSAM has developed the most comprehensive portfolio of pre-hospital emergency solutions in the Nordics, with its AMIS suite of products. AMIS is designed to support all aspects of emergency management, including Emergency Medical Communications Centres (EMCCs), mobile units such as ambulances, and emergency departments.
In an emergency,
The agreed Acquisition of ProSang company strengthens CSAM’s position as the leading provider of specialized solutions in the Nordic eHealth Market.